Renée Beekman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Renée Beekman has a total of 327 co-authors. Here are the top co-authors by number of shared publications:
- Jose Ignacio Martin-Subero
IDIBAPS, Barcelona, Spain
12 shared publications Marta Kulis
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
8 shared publications- Ana Cristina Queirós
Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal
6 shared publications - Elias Campo
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
6 shared publications - Ivo P. Touw
Department of Hematology Erasmus MC Cancer Institute Rotterdam the Netherlands
6 shared publications Agostina Bianchi
Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST) , C. Dr. Aiguader 88, Barcelona 08003
5 shared publications
Latest Publications
- Open Access
- 6 January 2026
- Published by Oxford University Press (OUP) in NAR Genomics and Bioinformatics
- Vol. 8 (1)
DNA methylation profiles aid to identify putative genome activation histories along lymphomagenesis
DNA methylation (DNAm) is widely used to leverage biological information in the context of cancer. Active regulatory elements marked by increased chromatin accessibility and specific transcription factor (TF) binding, such as enhancers, show tumor-specific DNAm patterns reflecting the biological forces shaping tumorigenesis. However, DNAm changes also occur at regions that are inactive at histone-mark level in fully developed tumors. Beyond hypermethylation of promoters, these changes are often overlooked, leaving their functional relevance poorly understood. By analyzing DNAm and chromatin state annotations from conventional mantle cell lymphoma (cMCL), we identified a subset of ~300 CpGs with homogeneous cMCL-specific demethylation patterns located in cMCL-inactive regions. We show that these regions contain cMCL-related TF motifs and are flanked by genes with cMCL-specific expression patterns, suggesting a potential regulatory role in lymphomagenesis. We hypothesize that these regions represent DNA demethylation imprints of genome activation prior to full-blown tumor formation, either present in its cell type of origin (COO) or during early stages of tumor formation. Altogether, we put forward a new, DNAm-centered approach to gain insights into potential early tumorigenic events, allowing us to generate novel, further explorable hypotheses to better understand the features playing a role in lymphomagenesis and beyond.
- 6 January 2026
- Published by Oxford University Press (OUP) in NAR Genomics and Bioinformatics
- Vol. 8 (1)
Open AccessDNA methylation profiles aid to identify putative genome activation histories along lymphomagenesis
DNA methylation (DNAm) is widely used to leverage biological information in the context of cancer. Active regulatory elements marked by increased chromatin accessibility and specific transcription factor (TF) binding, such as enhancers, show tumor-specific DNAm patterns reflecting the biological forces shaping tumorigenesis. However, DNAm changes also occur at regions that are inactive at histone-mark level in fully developed tumors. Beyond hypermethylation of promoters, these changes are often overlooked, leaving their functional relevance poorly understood. By analyzing DNAm and chromatin state annotations from conventional mantle cell lymphoma (cMCL), we identified a subset of ~300 CpGs with homogeneous cMCL-specific demethylation patterns located in cMCL-inactive regions. We show that these regions contain cMCL-related TF motifs and are flanked by genes with cMCL-specific expression patterns, suggesting a potential regulatory role in lymphomagenesis. We hypothesize that these regions represent DNA demethylation imprints of genome activation prior to full-blown tumor formation, either present in its cell type of origin (COO) or during early stages of tumor formation. Altogether, we put forward a new, DNAm-centered approach to gain insights into potential early tumorigenic events, allowing us to generate novel, further explorable hypotheses to better understand the features playing a role in lymphomagenesis and beyond.
- Open Access
- 11 August 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (15)
Translocations can drive expression changes of multiple genes in regulons covering entire chromosome arms
Chromosomal translocations have largely been implicated in tumor development. However, beyond the consequences of aberrant gene expression near the breakpoint, their effects remain underexplored. In this work, we characterize the interplay between translocations, chromatin organization and gene expression using mantle cell lymphoma (MCL) as a model. We show by in vitro genomic engineering and in MCL patient samples that translocations can drive transcriptional changes at entire chromosome arms affecting multiple genes in a regulon-like fashion. Moreover, we demonstrate a clear link between the translocation-induced transcriptional alterations and genome organization, with genes most susceptible to change expression forming pre-existing ultra-long-range interactions spanning 50 megabases. The translocation involves the strong immunoglobulin enhancer into this 3D interaction, allowing the spread of its regulatory potential over the entire affected chromosome arm. Finally, we show that translocation-induced effects mainly represent expression enhancement of genes already active prior to translocation formation, highlighting the importance of the epigenetic state of the cell in which this initial hit occurs. In summary, by studying genome organization principles in the context of translocations, we describe a new principle of gene regulation, showing that strong enhancers can induce substantial gene expression enhancement through ultra-long-range interactions affecting entire chromosome arms, representing an important new mechanism in health and disease.
- 11 August 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (15)
Open AccessTranslocations can drive expression changes of multiple genes in regulons covering entire chromosome arms
Chromosomal translocations have largely been implicated in tumor development. However, beyond the consequences of aberrant gene expression near the breakpoint, their effects remain underexplored. In this work, we characterize the interplay between translocations, chromatin organization and gene expression using mantle cell lymphoma (MCL) as a model. We show by in vitro genomic engineering and in MCL patient samples that translocations can drive transcriptional changes at entire chromosome arms affecting multiple genes in a regulon-like fashion. Moreover, we demonstrate a clear link between the translocation-induced transcriptional alterations and genome organization, with genes most susceptible to change expression forming pre-existing ultra-long-range interactions spanning 50 megabases. The translocation involves the strong immunoglobulin enhancer into this 3D interaction, allowing the spread of its regulatory potential over the entire affected chromosome arm. Finally, we show that translocation-induced effects mainly represent expression enhancement of genes already active prior to translocation formation, highlighting the importance of the epigenetic state of the cell in which this initial hit occurs. In summary, by studying genome organization principles in the context of translocations, we describe a new principle of gene regulation, showing that strong enhancers can induce substantial gene expression enhancement through ultra-long-range interactions affecting entire chromosome arms, representing an important new mechanism in health and disease.
- Top Cited PapersOpen Access
- 21 May 2025
- Published by Springer Nature in Nature
- Vol. 643 (8071) , 478-487
Clonal tracing with somatic epimutations reveals dynamics of blood ageing
Current approaches used to track stem cell clones through differentiation require genetic engineering1,2 or rely on sparse somatic DNA variants3,4, which limits their wide application. Here we discover that DNA methylation of a subset of CpG sites reflects cellular differentiation, whereas another subset undergoes stochastic epimutations and can serve as digital barcodes of clonal identity. We demonstrate that targeted single-cell profiling of DNA methylation5 at single-CpG resolution can accurately extract both layers of information. To that end, we develop EPI-Clone, a method for transgene-free lineage tracing at scale. Applied to mouse and human haematopoiesis, we capture hundreds of clonal differentiation trajectories across tens of individuals and 230,358 single cells. In mouse ageing, we demonstrate that myeloid bias and low output of old haematopoietic stem cells6 are restricted to a small number of expanded clones, whereas many functionally young-like clones persist in old age. In human ageing, clones with and without known driver mutations of clonal haematopoieis7 are part of a spectrum of age-related clonal expansions that display similar lineage biases. EPI-Clone enables accurate and transgene-free single-cell lineage tracing on hematopoietic cell state landscapes at scale.
- 21 May 2025
- Published by Springer Nature in Nature
- Vol. 643 (8071) , 478-487
Top Cited PapersOpen AccessClonal tracing with somatic epimutations reveals dynamics of blood ageing
Current approaches used to track stem cell clones through differentiation require genetic engineering1,2 or rely on sparse somatic DNA variants3,4, which limits their wide application. Here we discover that DNA methylation of a subset of CpG sites reflects cellular differentiation, whereas another subset undergoes stochastic epimutations and can serve as digital barcodes of clonal identity. We demonstrate that targeted single-cell profiling of DNA methylation5 at single-CpG resolution can accurately extract both layers of information. To that end, we develop EPI-Clone, a method for transgene-free lineage tracing at scale. Applied to mouse and human haematopoiesis, we capture hundreds of clonal differentiation trajectories across tens of individuals and 230,358 single cells. In mouse ageing, we demonstrate that myeloid bias and low output of old haematopoietic stem cells6 are restricted to a small number of expanded clones, whereas many functionally young-like clones persist in old age. In human ageing, clones with and without known driver mutations of clonal haematopoieis7 are part of a spectrum of age-related clonal expansions that display similar lineage biases. EPI-Clone enables accurate and transgene-free single-cell lineage tracing on hematopoietic cell state landscapes at scale.
- Open Access
Translocations can drive expression changes of multiple genes in regulons covering entire chromosome arms
Translocations have largely been implicated in tumor development. However, beyond the consequences of aberrant gene expression near the breakpoint, their effects remain unexplored. In this work, we characterize the interplay between translocations, chromatin organization and gene expression using mantle cell lymphoma (MCL) as a model. We show that in vitro induced MCL-associated translocations can drive transcriptional changes at entire chromosome arms affecting multiple genes in a regulon-like fashion. Additionally, overexpressed genes in MCL patients are enriched in the exact same genomic regions, further underlining its potential relevance for lymphomagenesis. Moreover, we demonstrate a clear link between the translocation-induced transcriptional alterations and genome organization, with genes most susceptible to change expression residing in pre-existing long-range interacting loops spanning 50 megabases. The translocation places the strong immunoglobulin enhancer into this loop, allowing the spread of its regulatory potential over the entire affected chromosome arm. Finally, we show that translocation-induced effects mainly represent expression enhancement of genes already active prior to translocation formation, highlighting the importance of the epigenetic state of the cell in which this initial hit occurs. In summary, we show that translocations can induce ample, simultaneous gene expression changes affecting entire chromosome arms, representing an important new mechanism for tumorigenesis.
Open AccessTranslocations can drive expression changes of multiple genes in regulons covering entire chromosome arms
Translocations have largely been implicated in tumor development. However, beyond the consequences of aberrant gene expression near the breakpoint, their effects remain unexplored. In this work, we characterize the interplay between translocations, chromatin organization and gene expression using mantle cell lymphoma (MCL) as a model. We show that in vitro induced MCL-associated translocations can drive transcriptional changes at entire chromosome arms affecting multiple genes in a regulon-like fashion. Additionally, overexpressed genes in MCL patients are enriched in the exact same genomic regions, further underlining its potential relevance for lymphomagenesis. Moreover, we demonstrate a clear link between the translocation-induced transcriptional alterations and genome organization, with genes most susceptible to change expression residing in pre-existing long-range interacting loops spanning 50 megabases. The translocation places the strong immunoglobulin enhancer into this loop, allowing the spread of its regulatory potential over the entire affected chromosome arm. Finally, we show that translocation-induced effects mainly represent expression enhancement of genes already active prior to translocation formation, highlighting the importance of the epigenetic state of the cell in which this initial hit occurs. In summary, we show that translocations can induce ample, simultaneous gene expression changes affecting entire chromosome arms, representing an important new mechanism for tumorigenesis.
- 2 October 2024
- Published by EMBL-EBI
Translocations can drive expression changes of multiple genes in regulons covering entire chromosome arms
BioStudies – one package for all the data supporting a study
- 2 October 2024
- Published by EMBL-EBI
Translocations can drive expression changes of multiple genes in regulons covering entire chromosome arms
BioStudies – one package for all the data supporting a study
- 29 April 2024
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 25 (8) , 533
The hidden world of transient enhancers
- 29 April 2024
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 25 (8) , 533
The hidden world of transient enhancers
- Open Access
- 26 October 2023
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 10, 1286716
The emerging field of opportunities for single-cell DNA methylation studies in hematology and beyond
The emerging field of opportunities for single-cell DNA methylation studies in hematology and beyond
- 26 October 2023
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 10, 1286716
Open AccessThe emerging field of opportunities for single-cell DNA methylation studies in hematology and beyond
The emerging field of opportunities for single-cell DNA methylation studies in hematology and beyond
- Open Access
- 28 October 2022
- Published by Springer Nature in Genome Biology
- Vol. 23 (1) , 1-17
scTAM-seq enables targeted high-confidence analysis of DNA methylation in single cells
Single-cell DNA methylation profiling currently suffers from excessive noise and/or limited cellular throughput. We developed scTAM-seq, a targeted bisulfite-free method for profiling up to 650 CpGs in up to 10,000 cells per experiment, with a dropout rate as low as 7%. We demonstrate that scTAM-seq can resolve DNA methylation dynamics across B-cell differentiation in blood and bone marrow, identifying intermediate differentiation states that were previously masked. scTAM-seq additionally queries surface-protein expression, thus enabling integration of single-cell DNA methylation information with cell atlas data. In summary, scTAM-seq is a high-throughput, high-confidence method for analyzing DNA methylation at single-CpG resolution across thousands of single cells.
- 28 October 2022
- Published by Springer Nature in Genome Biology
- Vol. 23 (1) , 1-17
Open AccessscTAM-seq enables targeted high-confidence analysis of DNA methylation in single cells
Single-cell DNA methylation profiling currently suffers from excessive noise and/or limited cellular throughput. We developed scTAM-seq, a targeted bisulfite-free method for profiling up to 650 CpGs in up to 10,000 cells per experiment, with a dropout rate as low as 7%. We demonstrate that scTAM-seq can resolve DNA methylation dynamics across B-cell differentiation in blood and bone marrow, identifying intermediate differentiation states that were previously masked. scTAM-seq additionally queries surface-protein expression, thus enabling integration of single-cell DNA methylation information with cell atlas data. In summary, scTAM-seq is a high-throughput, high-confidence method for analyzing DNA methylation at single-CpG resolution across thousands of single cells.
- Open Access
scTAM-seq enables targeted high-confidence analysis of DNA methylation in single cells
Single-cell DNA methylation profiling currently suffers from excessive noise and/or limited cellular throughput. We developed scTAM-seq, a targeted bisulfite-free method for profiling up to 650 CpGs in up to 10,000 cells per experiment, with a dropout rate of less than seven percent. scTAM-seq focuses sequencing coverage on informative, variably methylated CpGs that in many tissues and cell types make up a minor fraction of all CpGs. By applying scTAM-seq to B cells from blood and bone marrow, we demonstrate that it can resolve DNA methylation dynamics across B-cell differentiation at unprecedented resolution, identifying intermediate differentiation states that were previously masked. scTAM-seq additionally queries surface protein expression and somatic mutations, thus enabling integration of single-cell DNA methylation information with cell atlas data, and opening applications in tumor profiling. In summary, scTAM-seq is the first high-throughput, high-confidence method for analyzing DNA methylation at single-CpG resolution across thousands of single cells.
Open AccessscTAM-seq enables targeted high-confidence analysis of DNA methylation in single cells
Single-cell DNA methylation profiling currently suffers from excessive noise and/or limited cellular throughput. We developed scTAM-seq, a targeted bisulfite-free method for profiling up to 650 CpGs in up to 10,000 cells per experiment, with a dropout rate of less than seven percent. scTAM-seq focuses sequencing coverage on informative, variably methylated CpGs that in many tissues and cell types make up a minor fraction of all CpGs. By applying scTAM-seq to B cells from blood and bone marrow, we demonstrate that it can resolve DNA methylation dynamics across B-cell differentiation at unprecedented resolution, identifying intermediate differentiation states that were previously masked. scTAM-seq additionally queries surface protein expression and somatic mutations, thus enabling integration of single-cell DNA methylation information with cell atlas data, and opening applications in tumor profiling. In summary, scTAM-seq is the first high-throughput, high-confidence method for analyzing DNA methylation at single-CpG resolution across thousands of single cells.